Start Date: 20/12/2017

End Date: 20/12/2017

Cost: 180 / 120

Venue: South Kensington, London


The Royal Marsden NHS Foundation Trust

Contact Details:

For more information call 020 7808 2921

or email for further information


Immune checkpoint inhibitors represent the dawn of a new era in systemic cancer therapy and it is clear that immunotherapy agents will play an increasing role in cancer care over the coming years. This event will provide an overview of cancer immunotherapy, with a focus on the recognition and management of immune-mediated toxicities. The meeting will have a strong clinical emphasis, aimed at providing delegates with practical guidance that can be utilised in daily practice. This meeting will be of value to healthcare professionals involved in the delivery of cancer care including; doctors, nurses, pharmacists and physician associates working in oncology, acute medicine, emergency medicine, medical specialities and general practice. We look forward to seeing you in April.